Abstract
Purpose
This study evaluated the relationship between ultrasonographic (US) parameters of parathyroid glands (PTGs) in haemodialysis patients (HDP) and degree of secondary hyperparathyroidism (SHPT), therapeutic responsiveness and type of PTG hyperplasia (diffuse or nodular).
Materials and methods
In 85 HDP, we evaluated the following US parameters of all and of the largest PTGs: number, maximum longitudinal diameter (MLD), structural (hypoechoic, heterogeneous, nodular) and vascular (nonhypovascular, intermediate, hypervascular) echo-pattern scores. Sixty-nine HDP underwent medical therapy (vitamin D, 39; vitamin D/cinacalcet, 30) and 16 underwent parathyroidectomy. The 69 HDP were classified as responders [median intact parathyroid hormone (iPTH) ≤300 pg/ml during follow-up) or nonresponders (iPTH >300 pg/ml).
Results
Number, MLD and structural and vascular echo patterns of PTGs were significantly correlated with iPTH and calcium concentrations. In the 41 (59%) responders, number (0–1), MLD (<10 mm) and structural and vascular scores (1–2) of the largest PTG were significantly lower than in nonresponders. Receiver operating curve (ROC) curve analysis showed high sensitivity and specificity (90% and 73%, respectively) of the MLD (<10mm) of the largest PTG in the predicting therapeutic outcome. US and histological MLD are significantly correlated and predict the type of hyperplasia.
Conclusions
US parameters of PTGs are correlated to the degree of SHPT and type of hyperplasia and predict responsiveness to medical therapy.
Riassunto
Obiettivo
Scopo del presente lavoro è stato valutare le relazioni tra i parametri ecografici (US) paratiroidei (PTG) nei pazienti emodializzati (HDP) con la severità dell’iperparatiroidismo secondario (SHPT), la risposta alla terapia, il tipo d’iperplasia ghiandolare (diffusa o nodulare).
Materiali e metodi
In 85 HDP sono stati valutati i seguenti parametri US di tutte le PTG e di quella maggiore: diametro longitudinale massimo (MLD) gli ecopatterns strutturali (ipoecogeno, eterogeneo, nodulare] e vascolari (a-/ipo-vascolarizzato, intermedio, ipervascolarizzato). Sessantanove HDP sono stati sottoposti a terapia medica (39 con vitamina D; 30 con vitamina D/ cinacalcet) e 16 a paratiroidectomia. I 69 HDP sono stati classificati responders (R) [mediana ormone paratiroideo intatto (iPTH)≤300 pg/ml durante follow-up] o nonresponders (NR) (iPTH>300 pg/ml).
Risultati
Il numero di PTG, il MLD e gli eco-patterns strutturali e vascolari sono significamente correlati con calcemia e iPTH. In 41 (59%) R il numero (0–1), il MLD (<10 mm) e gli score strutturali e vascolari (1–2) della PTG maggiore erano significativamente inferiori rispetto ai NR. L’analisi della curva receiver operating curve (ROC) dimostra un’elevata sensibilità e specificità del MLD [90%/73%] della PTG maggiore (<10 mm) nel predire la risposta terapeutica. Il MLD ecografico ed istologico sono significativamente correlati e predicono il tipo di iperplasia.
Conclusioni
I parametri ecografici delle PTG sono correlati alla gravità del SHPT ed al tipo di iperplasia paratiroidea e predicono la risposta alla terapia medica.
Similar content being viewed by others
References/Bibliografia
Takebayashi S, Matsui K, Onohara Y et al (1987) Sonography for early diagnosis of enlarged parathyroid glands in patients with secondary hyperparathyroidism AJR Am J Roentgenol 5:911–918. DOI: 0361-803X/87/1485-0911
Ahuja AT, Wong KT, Ching ASC et al (2004) Imaging for primary hyperparathyroidism — what beginners should know. Clin Radiol 59:967–976. DOI: 10.1016/j.crad.2004.04.005
Barraclough BM, Barraclough BH (2000) Ultrasound of the thyroid and parathyroid glands. World J Surg 24:158–165. DOI: 10.1007/ s002689910028
Stark DD, Gooding GAW, Moss AA et al(1983) Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions. AJR Am J Roentgenol 141:633–638. DOI: 0361-803X/83/1414-0633
Kamaya A, Quon A, Jeffrey RB (2006) Sonography of the abnormal parathyroid gland. Ultrasound Q 22:253–262. DOI: 10.1097/01. ruq.0000237260.33509
Loevner LA (1996) Imaging of the parathyroid glands. Semin Ultrasound CT MR 17:563–575. DOI: 10.1016/S0887-2171(96)90004-9
Mazzeo S, Caramella D, Lencioni R (1997) Usefulness of echocolor Doppler in differentiating parathyroid lesions from other cervical masses. Eur Radiol 7:90–95. DOI: 10.1007/s11547-007-0179-8
Senschenkov A, Staren ED (2004) Ultrasound in head and neck surgery: thyroid, parathyroid and cervical lymph nodes. Surg Clin N Am 84:973–1000. DOI: 10.1016/j.suc.2004.04.007
Solbiati L, Osti V, Cova L, Tonolini M (2001) Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 11:2411–2416. DOI: 10 1007/s00330-001-1163-07
Tominaga Y, Tanaka Y, Sato K et al (1997) Histology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:78–86. DOI: 10.1002/(SICI)1098-2388(199703/04)13:2〈78::AIDSSU3〉3.0.CO;2-Z
Vulpio C, Bossola M, De Gaetano A et al (2010) Usefulness of the combination of ultrasonographyand 99mtc-sestamibi scintigraphy In the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32:1226–1235. DOI: 10.1002/ hed.21320
Guillem P, Vlaeminck-Guillem V, Dracon M et al (2006) Are preoperative examinations useful in the management of patients with renal hyperparathyroidism? Ann Chir 131:27–33. DOI: 10.1016/j.anchir2005.10.013
Perie S, Fessi H, Tassart M et al (2005) Usefulness of combination of high-resolution ultrasonography and dual-phase dual isotope iodine 123/technetium Tc99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 45:344–352. DOI: 10.1053/j.ajkd.2004.10.021
Pretolesi F, Silvestri E, Di Maio G et al (1997) US imaging and color-Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism. Eur Radiol 7:721–725. DOI 10.1007/BF02742933
Lane MJ, Desser TS, Weigel RJ (1998) Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas. AJR Am J Roentgenol 171:819–823. DOI: 0361-803X/98/1713-819
Kawata R, Kotetsu L, Takamaki A et al (2009) Ultrasonography for preoperative localization of enlarged parathyroid glands in secondary hyperparathyroidism. Auris Nasus Larynx 36:461–473. DOI: 10.1016/j. anl.2008.10.008
Fukagawa M, Kitaoka M, Yi H et al (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patient. Nephron 68:221–228. DOI: 10.1159/000188261
Fukagawa M, Kitaoka M, Kurokawa K (1997) Ultrasonographic evaluation of parathyroid hyperplasia. Nephrol Dial Transplant 12:2461–2463. DOI: 10.1093/ndt/12.11.2461
Tomic Brzac H, Pavlovic D, Halbauer M, Pasini J (1989) Parathyroid sonography in secondary hyperparathyroidism: correlation with clinical findings. Nephrol Dial Transplant 4:45–50. DOI: 10.1093/ndt/gfg1045
Pavlovic D, Tomic Brzac H (2006) Ultrasonographic evaluation of parathyroid hyperplasia in dialysis patients. ScientificWorld Journal 15:1599–1608. DOI: 10.1100/ tsw.2006.273
Katoh N, Nakayama M, Shigematsu T et al (2000) Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 35:465–468. DOI: 10.1016/ S0272-6386(00)70199-5
Okuno S, Ishimura E, Kitatani K et al (2003) Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 18:2613–2621. DOI: 10.1093/ndt/gfg451
Vulpio C, Bossola M, De Gaetano A et al (2008) Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism. Am J Nephrol 28:589–597. DOI: 10.1159/000116875
Vulpio C, Bossola M, De Gaetano A et al (2010) Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism. Ther Apher Dial 14:178–185. DOI: 10.1111/j.1744-9987.2009.00781.x
Vulpio C, Maresca G, Distasio E et al (2011) Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size. Hemodial Int 15:69–78. DOI: 10.1111/j.1542-4758.2010.00514.x
Onoda N, Kurihara S, Sakurai Y et al (2003) Evaluation of blood supply of the parathyroid glands in secondary hyperparathyroidism compared to histopathology. Nephrol Dial Transplant 18:iii34–iii37. DOI: 10.1093/ndt/gfg1009
Rodriguez M, Canalejo A, Garfia B et al (2002) Pathogenesis of refractory hyperparathyroidism. Kidney Int 61:155–160. DOI: 10.1046/j.1523-1775.61.s80.26.x
Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3–9. DOI: 10.1038/ki.1997.297
Matsuoka S, Tominaga Y, Sato T et al (2008) Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 12:391–395. DOI: 10.1111/j.1744-9987.2008.00615.x
National Kidney Foundation (2003) K/ DOQI 2003 clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201. DOI: 10.1016/S0272-6386(03)00905-3
Indridason OS, Heath H 3rd, Khosla S et al (1996) Non suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int 50:1663–1671. DOI: 10.1038/ ki.1996.483
Tominaga Y, Inaguma D, Matsuoka S et al (2006) Is the volume of the parathyroid gland a predictor of maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial 10:761–771. DOI: 10.1111/j.1744-9987.2006.00364.x
Komaba H, Nakanishi S, Fujimori A et al (2010) Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 5:2305–2314. DOI: 10.2215/CJN.02110310
Yamamoto M, Ogata H, Mizobuchi M et al (2012) Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol 16:292–299. DOI: 10.1007/s10157-011-0547-5
Fukuda N, Tanaka H, Fukagawa M et al (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443. DOI: 10.1172/JCI116720
Salem MM (1997) Hyperparathyroidism in the hemodialysis population: a survey of 612 patients. Am J Kidney Dis 29:862–865. DOI: 0272-6386/97/2906-0007$3.00-0
Doppman JL, Brennan MF, Khan CR et al (1981) Circumscribing or periadenomal vessel: a helpful angiographic finding in certain islet cell and parathyroid adenomas. AJR Am J Roentgenol 136:163–165. DOI: 0361-803X/81/1361-0163$S00.00
Lewin E, Olgaard K (2006) Influence of parathyroid mass on the regulation of PTH secretion. Kidney Int 70:S16–S21. DOI: 10.1038/sj.ki.5001597
Reeder SB, Desser TS, Weigel RJ et al (2002) Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med 21:539–552. DOI: 0278-4297/02/$3.50
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vulpio, C., Bossola, M., Magalini, S.C. et al. Parathyroid-gland ultrasonography in clinical and therapeutic evaluation of renal secondary hyperparathyroidism. Radiol med 118, 707–722 (2013). https://doi.org/10.1007/s11547-012-0882-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-012-0882-x